Skip to main content
Premium Trial:

Request an Annual Quote

Roche, St. Luke s Health System Establish Molecular Diagnostics Center in Kansas City

NEW YORK, Dec. 9 (GenomeWeb News) - Saint Luke's Health System, a Kansas City-based provider of molecular diagnostics and clinical testing, said today that it has signed a five-year strategic alliance agreement with Roche Diagnostics to establish a Molecular Center of Excellence to perform molecular diagnostic testing using Roche's PCR technology and other genomic technologies.

Financial terms of the agreement were not provided.

According to Saint Luke's Health System, molecular diagnostic testing will improve its diagnostic services "by providing more sensitive, more specific, and faster results so that patient treatment can be improved." Molecular testing should be able to measure the amount of a pathogen present in the system, allowing better treatment options, and will also provide accurate negative-predictive values when screening for genetic mutations in cystic fibrosis and other diseases, Saint Luke's said.

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.